OTC Primatene Mist epinephrine inhalers are next in line to be reformulated or pulled from the ma

February 2009

Please see updated information from the FDA concerning the phase-out of CFC inhalers

OTC Primatene Mist epinephrine inhalers are next in line to be reformulated or pulled from the market.

The current version will no longer be sold by the end of 2011 as part of the ban on CFC propellants. A new version with HFA propellant will probably be available by then.

This brings up the controversy as to whether asthma inhalers should be available OTC.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote